Marinus Pharma Reiterated As Outperform At Leerink

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Topics:  real-time   delivered   news   breaking   
BING NEWS:
  • SAGE Therapeutics: Hold Rating Reiterated Amid Clinical Trial Setbacks and Uncertainties
    Needham analyst Ami Fadia has reiterated their neutral stance on SAGE stock, giving a Hold rating yesterday. Ami Fadia has given his Hold ...
    04/17/2024 - 10:25 pm | View Link
  • Marinus Pharma Stock (NASDAQ:MRNS), Analyst Ratings, Price Targets, Predictions
    Marinus Pharmaceuticals Inc has a consensus price target of $17, established from looking at the 37 latest analyst ratings. The last 3 analyst ratings were released from Baird, HC Wainwright & Co ...
    12/4/2023 - 11:04 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News